Boc-L-beta-Glu(Bzl)-OH

Boc-L-beta-Glu(Bzl)-OH is a protected glutamic acid building block designed for peptide synthesis, featuring an N-terminal Boc protecting group and a benzyl-protected side-chain carboxylate (Bzl) on the glutamate residue. This protection pattern stabilizes both the amino functionality and the side-chain carboxyl during coupling and allows controlled deprotection at later stages when assembling glutamate-containing peptides. The stereochemistry is set for L-glutamate incorporation, making it a practical choice for constructing defined peptide sequences used in medicinal chemistry and protein/peptide research workflows.

1. Solid-Phase Peptide Synthesis

Boc-L-beta-Glu(Bzl)-OH is frequently used by peptide synthesis groups to incorporate glutamate residues into peptide sequences where the side-chain carboxyl must remain protected through chain assembly. The N-Boc group and benzyl ester protection help suppress undesired side reactions during iterative coupling and deprotection cycles, supporting reliable synthesis of glutamate-containing segments on solid supports. Researchers developing peptide libraries, reference peptides for structure-activity relationship studies, and sequence-defined standards for downstream characterization often select this protected glutamate form to maintain orthogonality with other residue side-chain protecting groups in their established synthesis strategy.

2. Glutamate-Containing Peptide Building Blocks

Boc-L-beta-Glu(Bzl)-OH supports the preparation of peptides and peptidomimetics that require a glutamate side chain for charge, hydrogen bonding, or conformational effects once deprotected. Custom peptide synthesis providers and medicinal chemistry teams use this residue building block when they need a glutamate side chain to be introduced in a protected, stable form during assembly, then revealed under conditions compatible with their overall deprotection plan. The benzyl-protected side-chain carboxylate is especially useful in workflows where the glutamate functionality must be preserved during earlier synthetic steps, enabling later generation of the free acidic side chain for biological assay development, binding studies, or material-binding peptide design.

3. Pharmaceutical Intermediate Development

Boc-L-beta-Glu(Bzl)-OH is also used as a glutamate-based intermediate in the development of peptide-derived or amino acid-derived chemical entities, where protected amino acid fragments are carried through multi-step syntheses. Process chemists and intermediate development teams select this compound when they need a defined, stereochemically consistent glutamate unit that can be coupled, elaborated, or incorporated into larger scaffolds while minimizing side reactions from both the α-amino and side-chain carboxyl groups. In this context, the Boc/Bzl protection pattern provides a practical handle for downstream transformations that require controlled exposure of functional groups at later stages of the synthetic sequence.

1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

2. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

3. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore

4. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

5. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients